Sponsored Links
| Immutep And GlaxoSmithKline Sign Licence Agreement For IMP731, A Novel Therapeutic Antibody For The Treatment Of Autoimmune Diseases |
 |
 |
 |
| Medical News - Immune System and Vaccines | |||
|
Immutep S.A. has announced the execution of a licence agreement granting GSK exclusive worldwide rights to ImmuTune(R) IMP731 and any other antibodies that deplete LAG-3 positive cells. IMP731 has demonstrated potency at low doses in preclinical models of T-cell mediated inflammation and could represent a new therapeutic approach to the treatment of autoimmune disease... Read more: Immune System / Vaccines News From Medical News Today
|